Literature DB >> 1645576

Polyclonal anti-idiotypic antibodies mimicking the small cell lung carcinoma antigen cluster-5A interact with a panel of antibodies and induce specific immune response in animals.

C Zwicky1, R A Stahel, H Jaksche, R Waibel, H P Lehmann, H Loibner.   

Abstract

Polyclonal anti-idiotypic antibodies (ab2) were generated by immunising goats with the murine IgG2a monoclonal antibody SWA20 which recognises the SCLC antigen cluster-5A, a tumour-associated sialoglycoprotein. Ab2 was shown to bind specifically to antibody SWA20, but not to isotype matched control antibodies. Pre-incubation with ab2 completely inhibited target cell binding of antibody SWA20 and of four other antibodies to cluster-5A antigen, while no effect was seen with antibodies to cluster-1 and cluster-w4 antigen. By these criteria the ab2 population consists of antibodies resembling in their reactivity pattern the cluster-5A antigen. Ab2 was used for immunisation of rabbits and two strains of mice; control animals received PBS or nonspecific goat IgG. Anti-anti-idiotype sera (ab3) were analysed in a series of radioimmunoassays for reactivity with goat IgG and reactivity with ab2. After blocking the nonspecific anti-goat response, ab3 could be shown to bind specifically to ab2 idiotype. As examined by an indirect cell ELISA with fixed cells, two out of six ab3 sera showed significantly higher binding ratios to antigen-positive SW2 cells as compared to antigen negative control cells. These findings indicate that the goat anti-SWA20 idiotype antibodies functionally represent the SCLC antigen cluster-5A and therefore may have potential for modulating the anti-tumour response through idiotypic network interactions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1645576      PMCID: PMC2204093     

Source DB:  PubMed          Journal:  Br J Cancer Suppl        ISSN: 0306-9443


  14 in total

1.  Tumor-associated membrane sialoglycoprotein on human small cell lung carcinoma identified by the IgG2a monoclonal antibody SWA20.

Authors:  R Waibel; C J O'Hara; A Smith; R A Stahel
Journal:  Cancer Res       Date:  1988-08-01       Impact factor: 12.701

2.  Cytotoxic murine monoclonal antibody LAM8 with specificity for human small cell carcinoma of the lung.

Authors:  R A Stahel; C J O'Hara; M Mabry; R Waibel; K Sabbath; J A Speak; S D Bernal
Journal:  Cancer Res       Date:  1986-04       Impact factor: 12.701

3.  Monoclonal anti-idiotypic antibody mimicking a tumor-associated sialoglycoprotein antigen induces humoral immune response against human small-cell lung carcinoma.

Authors:  A Barth; R Waibel; R A Stahel
Journal:  Int J Cancer       Date:  1989-05-15       Impact factor: 7.396

4.  Vaccination with syngeneic monoclonal anti-idiotype protects against a tumour challenge.

Authors:  P L Dunn; C A Johnson; J M Styles; S S Pease; C J Dean
Journal:  Immunology       Date:  1987-02       Impact factor: 7.397

5.  Altered tumor growth in vivo after immunization of mice with antitumor antibodies.

Authors:  R M Gorczynski; M Kennedy; I Polidoulis; G B Price
Journal:  Cancer Res       Date:  1984-08       Impact factor: 12.701

6.  Anti-idiotype immunization of cancer patients: modulation of the immune response.

Authors:  D Herlyn; M Wettendorff; E Schmoll; D Iliopoulos; I Schedel; U Dreikhausen; R Raab; A H Ross; H Jaksche; M Scriba
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

7.  Tumor idiotype vaccines. VI. Synergistic anti-tumor effects with combined "internal image" anti-idiotypes and chemotherapy.

Authors:  J J Chen; Y Saeki; L F Shi; H Köhler
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

Review 8.  Active specific immunotherapy with antiidiotypic antibodies in patients with solid tumors.

Authors:  M J O'Connell; Z J Chen; H Yang; M Yamada; M Massaro; A Mittelman; S Ferrone
Journal:  Semin Surg Oncol       Date:  1989

9.  Immunolocalisation and imaging of small cell cancer xenografts by the IgG2a monoclonal antibody SWA11.

Authors:  A Smith; R Waibel; G Westera; A Martin; A T Zimmerman; R A Stahel
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

10.  Suppression of in vivo tumor formation induced by simian virus 40-transformed cells in mice receiving antiidiotypic antibodies.

Authors:  R C Kennedy; G R Dreesman; J S Butel; R E Lanford
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.